✦ LIBER ✦

Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision

✍ Scribed by Marisa Donada, Serena Bonin, Renzo Barbazza, Daniel Pettirosso…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dilemma of Stage II Colon Cancer and Dec

✍ Fang, Sandy H.; Efron, Jonathan E.; Berho, Mariana E.; Wexner, Steven D. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 642 KB

Identification of Patients with High-Ris

✍ Hak-Mien Quah; Joanne F. Chou; Mithat Gonen; Jinru Shia; Deborah Schrag; Ron G. 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 137 KB

Pattern of Use of Adjuvant Chemotherapy

✍ Raymond U. Osarogiagbon; Jasgit C. Sachdev; Amna G. Khattak; Lori E. Kronish 📂 Article 📅 2009 🏛 CIG Media Group, LP. 🌐 English ⚖ 123 KB

Use of SERMs for the Adjuvant Therapy of

✍ ANTONIO C. WOLFF; NANCY E. DAVIDSON 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

The use of flow cytometry for the progno

✍ T. E. Kute; H. B. Muss; M. R. Cooper; L. D. Case; D. Buss; V. Stanley; B. Gregor 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 790 KB

Physicians’ Beliefs About the Benefits a

✍ Wong, A.C.; Stock, S.; Schrag, D.; Kahn, K.L.; Salz, T.; Charlton, M.E.; Rogers, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB